x
Visit our new Mobile Website next time you access NetDania with your mobile device

CITIUS PHARMACEUTICALS INC. - COMMON STOCK

0.7050
03-19:59:55 GMT
-0.0020
-0.2829%
ISIN:N/A

Figures - CITIUS PHARMACEUTICALS INC. - COMMON STOCK

Open
0.7300
Close
0.7070
Year Change
-6.8077
Year % Change
-6.8077%
52 Week High
1.4500
52 Week Low
0.6000
Volume
671810
Inc. Vol
33279

News - CITIUS PHARMACEUTICALS INC. - COMMON STOCK

05-10:18 GMT
Kentucky Derby 2024 Results: Mystik Dan Wins By A Nose, Sierra Leone Places, Forever Young Shows
Source: Forbes World, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
05-10:04 GMT
Does Alphabet's Dividend Mean Anything to Investors?
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
05-10:04 GMT
2 High-Yield Dividend Stocks Billionaires Are Buying Hand Over Fist
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
05-10:04 GMT
1 Wall Street Analyst Thinks Roku Stock Is Going to $74. Is It a Buy Around $60?
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
05-10:04 GMT
This 1 Catalyst From Coinbase Could Send Solana Meme Coins Skyward
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
05-10:04 GMT
The S&P 500 Is Near an All-Time High: This Strategy From Expert Investors Could Significantly Lower Your Risk
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
05-10:04 GMT
05-10:01 GMT
After Grilling Presidents, Congress Takes Aim At College Funding
Source: Forbes World, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
05-10:01 GMT
Inside ‘Dragonfly,’ NASA’s Jaw-Dropping New Drone Mission To Reveal Titan
Source: Forbes World, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
05-10:01 GMT
Passive Income: How To Multiply Your Money With Minimal Effort
Source: Forbes World, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
05-10:01 GMT
Your Psychedelic Gummy Is Here. (Have A Nice Trip.)
Source: Forbes World, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
05-10:01 GMT
Sony Is Making A Truly Terrible Mistake With ‘Helldivers 2’
Source: Forbes World, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
05-10:01 GMT
The Mokibo Fusion Keyboard 2.0 Will Turn Your iPad Into A MacBook
Source: Forbes World, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
05-09:59 GMT
Real Madrid Now Wants To Renew Player’s Contract, Reports MARCA
Source: Forbes World, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
05-09:37 GMT
Pinterest Pops Following Its Q1 Results. Is It Too Late to Buy the Stock?
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
05-09:37 GMT
Is It Time to Buy April's Worst-Performing Dow Jones Stocks?
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
05-09:37 GMT
05-09:37 GMT
3 Top Stocks to Buy Now That Could Help You Retire a Millionaire
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
05-09:37 GMT
Here's My Pick for the Best Mega-Cap Artificial Intelligence (AI) Stock to Buy Right Now
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
05-09:37 GMT
Enphase Believes the Worst of the Solar Market Downturn Is Over. Is That Enough to Make It a Buy?
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
05-09:37 GMT
40.3% of Warren Buffett's $336 Billion Portfolio Is Invested in Apple. Should You Buy the Stock, Too?
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
05-09:08 GMT
No, Amazon Shouldn't Pay a Dividend. Here's the Simple Reason Why
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
05-09:08 GMT
Here's the Largest COLA Social Security Has Ever Paid. 2025's Won't Be Anywhere Close
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
05-09:08 GMT
4 Invesco ETFs That Could Help You Retire a Millionaire
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
05-09:02 GMT
The World’s 15 Safest Cities (2 U.S. Cities Made The List), Ranked In A New Report
Source: Forbes World, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
05-09:01 GMT
Messi Makes MLS Assist History. What Other Records Will He Break?
Source: Forbes World, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
05-08:57 GMT
The World’s Best Bourbon—According To The 2023 International Spirits Challenge
Source: Forbes World, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
05-08:56 GMT
Can Iga Swiatek Make The French Open Hers To Keep After Madrid Win?
Source: Forbes World, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
05-08:43 GMT
Lionel Messi Makes History As Inter Miami Hit NY Red Bulls For Six
Source: Forbes World, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
05-08:41 GMT
Beat the S&P 500 With This Cash-Gushing Dividend Stock
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
05-08:41 GMT
Alibaba Stock: Buy, Sell, or Hold?
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
05-08:41 GMT
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
05-08:41 GMT
The Ultimate Growth Stock to Buy With $100 Right Now
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
05-08:41 GMT
Why British American Tobacco's Big Shift Is So Important for High-Yield Investors
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
05-08:41 GMT
Elbit Systems Secures $37 Mln Contract To Equip U.S. Army's Bradley IFVs With Iron Fist APS
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
05-08:36 GMT
Rolling Stones Impact Rhone Valley Rasteau Wines
Source: Forbes World, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
05-08:36 GMT
Rhone Valley Rasteau Wines Tasted For Value
Source: Forbes World, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
05-08:14 GMT
1 Hot Nasdaq Stock to Buy Hand Over Fist Before It Soars at Least 25% Thanks to the Artificial Intelligence (AI) Boom
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
05-08:14 GMT
Billionaire Investor Ken Griffin Owns $1.7 Billion of Nvidia Stock. Should You Be Buying it Hand Over Fist?
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
05-08:14 GMT
Where Will Intel Stock Be in 5 Years?
Source: NASDAQ US Markets, Symbol: CITIUS PHARMACEUTICALS INC. - COMMON STOCK
Five Star Chart – Build your favorite menu, 100+ studies, for mobile and desktop
Find a Top Broker
Global
Forex
38710.32
232.22
0.60%
5136.15
50.42
0.99%
17925.05
281.68
1.60%
63680.22
-218.78
-0.34%
18082.16
81.26
0.45%
38359.03
382.61
1.01%
3104.82
-8.22
-0.26%
8250.62
57.34
0.70%
18598.41
12.29
0.07%
7657.10
35.28
0.46%
22475.85
-172.35
-0.76%
2300.96
-3.22
-0.14%
82.80
-0.939
-1.12%
1.07580
0.00283
0.26%
152.948
-0.189
-0.12%
1.25455
0.00062
0.05%
0.66081
0.00383
0.58%
1.36848
0.00184
0.13%
164.56500
0.246
0.15%
0.85761
0.00192
0.22%
191.88800
-0.133
-0.07%
0.90462
-0.00512
-0.56%
0.97221
-0.00393
-0.40%
0.60094
0.00457
0.77%
105.07600
-0.268
-0.25%
Top Gainers
Name
Last
+/-
%
6.82
4.90
255.21%
5.54
2.61
89.08%
0.02
0.01
78.43%
0.33
0.11
49.28%
0.45
0.14
45.16%
0.07
0.02
41.78%
0.02
0.00
38.46%
0.09
0.02
38.46%
8.21
2.28
38.45%
0.02
0.01
38.01%
Top Losers
Name
Last
+/-
%
3.39
-18.68
-84.64%
0.00
-0.01
-59.00%
2.04
-2.67
-56.69%
0.02
-0.03
-55.88%
0.05
-0.04
-45.32%
0.01
-0.01
-43.20%
0.02
-0.02
-42.86%
0.02
-0.01
-42.67%
0.04
-0.03
-41.69%
28.82
-19.33
-40.14%
NetDania does not guarantee the accuracy of data contained on this website, nor do we guarantee that data is real-time. Data on this website may be provided from OTC market sources and market makers, and not necessarily from exchanges. The provided price data is indicative and may not be appropriate for trading or decision making purposes. NetDania does not assume any responsibility for any losses incurred from the use of the provided data.
NetDania does not endorse or promote any broker or financial service. NetDania is a pure technology provider offering its software with broker integration. Any user of NetDania software must be an existing client of one of our supported brokers. NetDania showcases NetDania technology for the purpose of demonstrating it towards brokers and other institutions looking to white label the technology on a software subscription contract. No financial services are offered, promoted or recommended. NetDania is compensated as a technology provider by its institutional clients including its integrated brokers. It is the sole responsibility of any recipient employing or requesting an offering to comply with all applicable legislation or regulation affecting it.

Persons or entities including approved brokers not belonging to the NetDania Group may advertise on the NetDania and its Group’s websites, through links, banners or otherwise. We have not taken any steps to verify the accuracy, quality or reliability of any products, information or services provided by third parties that have links on our website. We accordingly provide no warranties with regard to and disclaim responsibility for any such products, information or services and exclude all liability in this regard to the fullest extent permitted by relevant laws and regulations. If a user of the NetDania Group’s websites decides to act upon any such advertising, such user does so entirely at its own risk.

NetDania’s website may be accessed worldwide. The Information provided on its website is however only intended for use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. None of the offerings services referred to on this website are available to recipients residing in countries where the provision of such offerings would constitute a violation of mandatory applicable legislation or regulations. It is the sole responsibility of any recipient employing or requesting an offering to comply with all applicable legislation or regulation.

HIGH RISK INVESTMENT WARNING:
End-users of the NetDania software that make use of the trading integration features as direct clients of integrated brokers, should be aware of the level of risk carried by trading in financial markets. Trading foreign exchange and or other financial instruments on margin carries a high level of risk, and may not be suitable for all investors. The high degree of leverage can work against you as well as for you. Before deciding to invest you should carefully consider your investment objectives, level of experience, and risk appetite. The possibility exists that you could sustain a loss of some or more of your initial investment, and therefore you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with trading, and seek advice from your broker and or an independent financial advisor if you have any doubts. Anyone opening a live trading account needs to adhere to the laws of their local country as such laws may differ from country to country.
NetDania expressly disclaims any liability for any lost principal or profits which without limitation may arise directly or indirectly from the use of or reliance on information on our website or the use of our software with broker integration.
Copyright © 1998 -2024 NetDania Creations ApS, Holmens Kanal 7, 1060 Copenhagen K, Denmark, +4536988200, Contact NetDania by email, CVR-nr.27976670 Terms And Conditions and Privacy Policy